Patent applications and USPTO patent grants for WAVE LIFE SCIENCES LTD..The latest application filed is for "double-stranded nucleic acid complex and use thereof".
Patent | Date |
---|---|
Double-stranded Nucleic Acid Complex And Use Thereof App 20220307019 - YOKOTA; Takanori ;   et al. | 2022-09-29 |
Oligonucleotide Compositions And Methods Of Use Thereof App 20220306573 - Zhang; Jason Jingxin ;   et al. | 2022-09-29 |
Compositions and methods for phosphoramidite and oligonucleotide synthesis Grant 11,407,775 - Butler , et al. August 9, 2 | 2022-08-09 |
Oligonucleotide Compositions And Methods Thereof App 20220195429 - Vargeese; Chandra ;   et al. | 2022-06-23 |
Oligonucleotide Compositions And Methods Thereof App 20220186217 - Zhang; Jason Jingxin ;   et al. | 2022-06-16 |
Oligonucleotide Compositions And Methods Thereof App 20220162598 - Vargeese; Chandra ;   et al. | 2022-05-26 |
Oligonucleotide Compositions And Methods Of Use Thereof App 20220145300 - Liu; Yuanjing ;   et al. | 2022-05-12 |
Asymmetric Auxiliary Group App 20220127301 - Shimizu; Mamoru ;   et al. | 2022-04-28 |
Oligonucleotide Compositions And Methods Thereof App 20220098585 - Brown; Jeffrey Matthew ;   et al. | 2022-03-31 |
Asymmetric auxiliary group Grant 11,136,346 - Shimizu , et al. October 5, 2 | 2021-10-05 |
Oligonucleotide Compositions And Methods Of Use Thereof App 20210254062 - Zhang; Jason Jingxin ;   et al. | 2021-08-19 |
Oligonucleotide Compositions And Methods Thereof App 20210228615 - Zhang; Jason Jingxin ;   et al. | 2021-07-29 |
Oligonucleotide Compositions And Methods Of Use Thereof App 20210198305 - Vargeese; Chandra ;   et al. | 2021-07-01 |
Oligonucleotides, compositions and methods thereof Grant 11,013,757 - Zhang , et al. May 25, 2 | 2021-05-25 |
Chiral Control App 20210130821 - Butler; David Charles Donnell ;   et al. | 2021-05-06 |
Chiral Design App 20210115444 - Meena; ;   et al. | 2021-04-22 |
Oligonucleotide Compositions And Methods Thereof App 20210032620 - Vargeese; Chandra ;   et al. | 2021-02-04 |
Asymmetric Auxiliary Group App 20200385420 - Shimizu; Mamoru ;   et al. | 2020-12-10 |
Oligonucleotide Compositions And Methods Thereof App 20200362337 - Dodart; Jean-Cosme ;   et al. | 2020-11-19 |
Chiral design Grant 10,815,482 - Meena , et al. October 27, 2 | 2020-10-27 |
Oligonucleotide Compositions And Methods Thereof App 20200299692 - Frank-Kamenetsky; Maria David ;   et al. | 2020-09-24 |
Oligonucleotide compositions and methods thereof Grant 10,724,035 - Vargeese , et al. | 2020-07-28 |
Technologies For Oligonucleotide Preparation App 20200231620A1 - | 2020-07-23 |
Asymmetric auxiliary group Grant 10,696,711 - Shimizu , et al. June 30, 2 | 2020-06-30 |
Oligonucleotide Compositions And Methods Of Use Thereof App 20200190515A1 - | 2020-06-18 |
Oligonucleotide Compositions And Methods Of Use Thereof App 20200157545 - Vargeese; Chandra ;   et al. | 2020-05-21 |
Chiral control Grant 10,590,413 - Butler , et al. | 2020-03-17 |
Oligonucleotide Compositions And Methods Thereof App 20200080083 - Vargeese; Chandra ;   et al. | 2020-03-12 |
Oligonucleotide Compositions And Methods Thereof App 20200056173 - Vargeese; Chandra ;   et al. | 2020-02-20 |
Oligonucleotide Compositions And Methods Thereof App 20190390197 - Butler; David Charles Donnell ;   et al. | 2019-12-26 |
Compositions And Methods For Phosphoramidite And Oligonucleotide Synthesis App 20190375774 - Butler; David Charles Donnell ;   et al. | 2019-12-12 |
Oligonucleotide compositions and methods thereof Grant 10,479,995 - Vargeese , et al. Nov | 2019-11-19 |
Oligonucleotide compositions and methods thereof Grant 10,450,568 - Butler , et al. Oc | 2019-10-22 |
Chiral auxiliaries Grant 10,428,019 - Wada , et al. October 1, 2 | 2019-10-01 |
Phasing App 20190264267 - YANG; Hailin ;   et al. | 2019-08-29 |
Methods And Compositions Of Biologically Active Agents App 20190249173 - Vargeese; Chandra ;   et al. | 2019-08-15 |
Oligonucleotides, Compositions And Methods Thereof App 20190209604 - Zhang; Jason Jingxin ;   et al. | 2019-07-11 |
Method for the synthesis of phosphorus atom modified nucleic acids Grant 10,329,318 - Wada , et al. | 2019-06-25 |
Asymmetric Auxiliary Group App 20190177357 - Shimizu; Mamoru ;   et al. | 2019-06-13 |
Nucleic acid prodrugs and methods of use thereof Grant 10,307,434 - Verdine , et al. | 2019-06-04 |
Methods for the synthesis of functionalized nucleic acids Grant 10,280,192 - Verdine , et al. | 2019-05-07 |
Oligonucleotide Compositions And Methods Thereof App 20190127733 - Butler; David Charles Donnell ;   et al. | 2019-05-02 |
Chiral Design App 20190106696 - Meena; ;   et al. | 2019-04-11 |
Compositions And Methods For Phosphoramidite And Oligonucleotide Synthesis App 20190077817 - Butler; David Charles Donnell ;   et al. | 2019-03-14 |
Oligonucleotide Compositions And Methods Thereof App 20190008986 - Butler; David Charles Donnell ;   et al. | 2019-01-10 |
Asymmetric auxiliary group Grant 10,167,309 - Shimizu , et al. J | 2019-01-01 |
Chiral design Grant 10,160,969 - Meena , et al. Dec | 2018-12-25 |
Methods For The Synthesis Of Functionalized Nucleic Acids App 20180222936 - Verdine; Gregory L. ;   et al. | 2018-08-09 |
Chiral control Grant 9,982,257 - Butler , et al. May 29, 2 | 2018-05-29 |
Chiral Control App 20170275621 - Butler; David Charles Donnell ;   et al. | 2017-09-28 |
Nucleic acid prodrugs and methods of use thereof Grant 9,744,183 - Verdine , et al. August 29, 2 | 2017-08-29 |
Methods for the synthesis of functionalized nucleic acids Grant 9,605,019 - Verdine , et al. March 28, 2 | 2017-03-28 |
Chiral Design App 20170037399 - ; ; Meena ;   et al. | 2017-02-09 |
Methods For The Synthesis Of Functionalized Nucleic Acids App 20170029457 - Verdine; Gregory L. ;   et al. | 2017-02-02 |
Novel Nucleic Acid Prodrugs And Methods Of Use Thereof App 20160347784 - Verdine; Gregory L. ;   et al. | 2016-12-01 |
SEC | 0001631574 | Wave Life Sciences Ltd. of SINGAPORE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.